SCHEMBL5543583

SCHEMBL5543583

CC(C)(C)c1nc(NCCc2cccnc2)c2n[nH]c(=O)n2c1C(O)CCc1ccc(Cl)cc1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 2/20 0.43
GSK3B P49841 5/20 0.41
GSK3A P49840 4/20 0.41
TBXAS1 P24557 4/20 0.36
ALDH1A1 P00352 1/20 0.35
MAPT P10636 1/20 0.35
AURKB Q96GD4 1/20 0.34
SLC1A3 P43003 1/20 0.34
SLC1A2 P43004 1/20 0.34
SLC1A1 P43005 1/20 0.34
ESR1 P03372 1/20 0.34
ESR2 Q92731 1/20 0.34
HDAC8 Q9BY41 1/20 0.33
ADRB2 P07550 1/20 0.33
ADRB1 P08588 1/20 0.33
ADRB3 P13945 1/20 0.33
JAK3 P52333 1/20 0.33
F2 P00734 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5549322 0.94 ADORA1 (0.45) ADORA1GSK3BGSK3AJAK3F2
SCHEMBL5545500 0.94 ADORA1 (0.49) ADORA1GSK3BGSK3AMAPTJAK3
SCHEMBL5549397 0.92 ADORA1 (0.43) ADORA1GSK3BGSK3ASLC1A3SLC1A2
SCHEMBL5548564 0.91 ADORA1 (0.42) ADORA1GSK3BGSK3ATBXAS1AURKB
SCHEMBL5549074 0.90 ADORA1 (0.49) ADORA1GSK3BGSK3ATBXAS1JAK3
SCHEMBL5543584 0.87 ADORA1 (0.40) ADORA1GSK3BGSK3ATBXAS1ALDH1A1
SCHEMBL3525368 0.86 ADORA1 (0.44) ADORA1GSK3BGSK3AJAK3F2
SCHEMBL5548882 0.85 ADORA1 (0.45) ADORA1GSK3BGSK3AJAK3F2
SCHEMBL5543503 0.82 ADORA1 (0.50) ADORA1GSK3BGSK3AJAK3F2
SCHEMBL5548920 0.80 ADORA1 (0.50) ADORA1GSK3BGSK3AJAK3F2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678180-B1 SUBSTITUTED 2H-[1,2,4]TRIAZOLO 4,3-A PYRAZINES AS GSK-3 INHIBITORS PFIZER PROD INC (US) 2007-08-08 EP disclosed